Table 2.
Study | n | Arterial stenosis | Technique | Follow‐up period | Success rate |
---|---|---|---|---|---|
Castaneda‐Zunga 1982 | 2 | Internal iliac | PTA | 18 months | 2/2 (100%) |
Van Unnik 1984 | 1 | External iliac | PTA | N/A | 1/1 (100%) |
Goldwasser 1985 | 1 | Internal iliac | N/A | N/A | 1/1 (100%) |
Dewar 1985 | 30 |
70% aorto‐iliac 47% internal iliac |
PTA | N/A | 10/33 (33%) |
Angelini 1985 | 5 | Internal iliac | PTA | 2‐18 months | 4/5 (80%) |
Valji 1988 | 3 | N/A | PTA | N/A | N/A |
Urigo 1994 | 23 |
65% internal iliac 13% internal pudendal |
N/A | N/A |
15/23 (65%) 3/3 (100%) |
Rogers 2011 | 30 | Internal pudendal | PTA and DESs | 3 months |
68.2% had improvement in IIEF‐5 score ≥ 4 |
Wang 2014 | 20 |
59% Common penile 38% Dorsal penile 3% Cavernosal |
PTA | 6 months |
Clinical success a 12/20 (60%) |
Wang 2016 | 22 |
73% Common penile 24% Dorsal penile 3% Cavernosal |
PTA | 12 months |
Clinical success a 11/22 (50%) |
Wang 2018 | 182 |
19% internal iliac 47% internal pudendal 29% penile/cavernosal 5% accessory pudendal |
PTA/stents | 12 months |
Any improvement in IIEF‐5 score ≥ 4 within 12 months 134/182 (74%) Clinical success a 112/182 (62%) |
Abbreviations: IIEF, International Index on Erectile Function; N/A, not available; PTA, percutaneous transluminal balloon angioplasty.
Clinical success was defined as improvement in the IIEF‐5 score ≥ 4 or normalization of erectile function (IIEF‐5 ≥ 22).